NK-cell enteropathy: genes and variants
Explore variant evidence for NK-cell enteropathy across 6 analyzed proteins (AURKB, AXL, CUL3, ERBB4, PIK3CB and 1 more). Linked ClinVar records include 7 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to NK-cell enteropathy
AURKB: Aurora kinase B
It controls chromosome alignment, kinetochore-microtubule attachment, the spindle checkpoint, and cytokinesis as part of the chromosomal passenger complex. Excess activity is common in proliferative cancers and can contribute to aneuploidy and treatment resistance.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in AURKB have source records linked to NK-cell enteropathy. Association strength is not clinical gene validity.
AXL: Tyrosine-protein kinase receptor UFO
Activation by GAS6 promotes cell survival, migration, immune modulation, and resistance to cellular stress. Persistent signaling is common in advanced cancers and can support epithelial-to-mesenchymal transition, metastasis, and resistance to targeted or immune therapies.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in AXL have source records linked to NK-cell enteropathy. Association strength is not clinical gene validity.
CUL3: Cullin-3
It serves as a scaffold for multiple ubiquitin-ligase complexes that control degradation of signaling and regulatory proteins, including components of the KEAP1-NRF2 pathway. Pathogenic variants can cause pseudohypoaldosteronism type II and neurodevelopmental disorders, while somatic alterations affect cancer signaling.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CUL3 have source records linked to NK-cell enteropathy. Association strength is not clinical gene validity.
ERBB4: Receptor tyrosine-protein kinase erbB-4
It transduces neuregulin and other EGF-family signals important for neural, cardiac, and mammary development. Altered signaling or somatic variants occur in several cancers and have also been studied in neurodevelopmental disease.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ERBB4 have source records linked to NK-cell enteropathy. Association strength is not clinical gene validity.
PIK3CB: Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
It generates PIP3 downstream of growth-factor and G-protein-coupled receptors, activating AKT and other signaling pathways that regulate survival and metabolism. Some PTEN-deficient tumors become particularly dependent on p110beta activity, making it a therapeutic target.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PIK3CB have source records linked to NK-cell enteropathy. Association strength is not clinical gene validity.
SMARCB1: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1
Within SWI/SNF complexes, it constrains oncogenic transcription and supports normal chromatin regulation. Biallelic tumor-cell inactivation is characteristic of malignant rhabdoid tumors, while germline variants predispose to rhabdoid tumors or schwannomatosis.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SMARCB1 have source records linked to NK-cell enteropathy. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to NK-cell enteropathy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| AXL L721V | 721 | Protein kinase | Pathogenic / likely pathogenic |
| ERBB4 C262Y | 262 | Extracellular | Pathogenic / likely pathogenic |
| AURKB R283C | 283 | Protein kinase | Pathogenic / likely pathogenic |
| CUL3 G500D | 500 | Pathogenic / likely pathogenic | |
| PIK3CB E987D | 987 | PI3K/PI4K catalytic | Pathogenic / likely pathogenic |
| SMARCB1 R377G | 377 | Pathogenic / likely pathogenic | |
| AURKB R284C | 284 | Protein kinase | Pathogenic / likely pathogenic |
Same protein, different disease
- Pseudohypoaldosteronism type 2E also has ClinVar records linked to CUL3 variants; they fall mostly in different places as the NK-cell enteropathy variants (7 pathogenic / likely pathogenic).
- Neurodevelopmental disorder with or without autism or seizures also has ClinVar records linked to CUL3 variants; they fall mostly in different places as the NK-cell enteropathy variants (3 pathogenic / likely pathogenic).
Diseases related to NK-cell enteropathy
- Alzheimer disease, also linked to AURKB and AXL
- Parkinson disease, also linked to AURKB and AXL
- Multiple sclerosis, also linked to AURKB and AXL
- Amyotrophic lateral sclerosis, also linked to ERBB4
- Acute myeloid leukemia, also linked to AXL
- Coffin-Siris syndrome, also linked to SMARCB1
- Non-small cell lung carcinoma, also linked to ERBB4
- Rhabdoid tumor predisposition syndrome, also linked to SMARCB1
- Pseudohypoaldosteronism type 2E, also linked to CUL3
- Neurodevelopmental disorder with or without autism or seizures, also linked to CUL3
- Medullary thyroid carcinoma, also linked to ERBB4
Frequently asked questions
Which genes have records linked to NK-cell enteropathy?
This view contains 6 analyzed proteins: AURKB, AXL, CUL3, ERBB4, PIK3CB and 1 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 7 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 7 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center